back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-07-15 21:54 Tx date 2025-07-11 |
$MIST
Milestone Pharmaceuticals Inc. |
Papa, Joseph
4 - Director of Issuer
Direct Ownership
|
Warrants Series B Common Warrants
53 - Grant of warrants
|
+100,000 vol |
100,000 | |
| Filed 2025-07-15 21:54 Tx date 2024-09-03 |
$MIST
Milestone Pharmaceuticals Inc. |
Papa, Joseph
4 - Director of Issuer
Direct Ownership
|
Warrants Series B Common Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-07-15 21:54 Tx date 2025-07-11 |
$MIST
Milestone Pharmaceuticals Inc. |
Papa, Joseph
4 - Director of Issuer
Direct Ownership
|
Warrants Series A Common Warrants
53 - Grant of warrants
|
+100,000 vol |
100,000 | |
| Filed 2025-07-15 21:53 Tx date 2024-09-03 |
$MIST
Milestone Pharmaceuticals Inc. |
Papa, Joseph
4 - Director of Issuer
Direct Ownership
|
Warrants Series A Common Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-07-15 21:53 Tx date 2025-07-11 |
$MIST
Milestone Pharmaceuticals Inc. |
Papa, Joseph
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$150,000
+100,000 vol $1.50 each |
100,000 | |
| Filed 2025-07-15 21:51 Tx date 2024-09-03 |
$MIST
Milestone Pharmaceuticals Inc. |
Papa, Joseph
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-06-12 17:02 Tx date 2025-06-10 |
$MIST
Milestone Pharmaceuticals Inc. |
Papa, Joseph
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,000 vol |
120,000 | |
| Filed 2024-09-05 18:10 Tx date 2024-09-03 |
$MIST
Milestone Pharmaceuticals Inc. |
Papa, Joseph
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+80,000 vol |
80,000 | |
| Filed 2024-09-05 18:10 Tx date 2024-09-03 |
$MIST
Milestone Pharmaceuticals Inc. |
Papa, Joseph
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-09-15 15:30 Tx date 2022-09-14 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-762,430
-100,000 vol $7.62 each |
934,594 | |
| Filed 2022-09-15 15:29 Tx date 2022-09-14 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-389,000
-50,000 vol $7.78 each |
1,034,594 | |
| Filed 2022-09-15 15:26 Tx date 2022-09-13 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-26,665.28
-3,623 vol $7.36 each |
1,084,594 | |
| Filed 2022-09-15 15:26 Tx date 2022-09-13 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$52,130
+7,083 vol $7.36 each |
1,088,217 | |
| Filed 2022-09-15 15:25 Tx date 2022-09-13 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-7,083 vol |
76,448 | |
| Filed 2022-05-16 17:04 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-316,911.60
-33,714 vol $9.40 each |
1,081,134 | |
| Filed 2022-05-16 17:03 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$619,563
+65,911 vol $9.40 each |
1,114,848 | |
| Filed 2022-05-16 17:02 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-65,911 vol |
983,705 | |
| Filed 2022-05-16 17:00 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
97 - Other
|
$619,563
+65,911 vol $9.40 each |
1,049,616 | |
| Filed 2022-05-16 16:57 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
97 - Other
|
$1,725,106
+183,522 vol $9.40 each |
983,705 | |
| Filed 2022-05-16 16:56 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
97 - Other
|
$1,096,951
+116,697 vol $9.40 each |
800,183 |